• Return to Headlines

Shares of Anika Therapeuti Rank the Lowest in Terms of EBITDA Growth in the Health Care Supplies Industry (ANIK, RTIX, NEOG, WST, COO)

By Amy Schwartz

Below are the three companies in the Health Care Supplies industry with the lowest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Anika Therapeuti ranks lowest with a EBITDA growth of -21.2%. Following is Rti Surgical Inc with a EBITDA growth of -0.7%. Neogen Corp ranks third lowest with a EBITDA growth of 18.3%.

West Pharmaceut follows with a EBITDA growth of 33.4%, and Cooper Cos Inc rounds out the bottom five with a EBITDA growth of 41.1%.

SmarTrend recommended that its subscribers protect gains by selling shares of Neogen Corp on September 24th, 2019 by issuing a Downtrend alert when the shares were trading at $67.29. Since that call, shares of Neogen Corp have fallen 4.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest ebitda growth anika therapeuti rti surgical inc neogen corp west pharmaceut cooper cos inc

Ticker(s): ANIK RTIX NEOG WST COO